Weight Loss - Search News

Eli Lilly's New Drug Shows Double The Weight Loss Of Ozempic

New weight loss drug provides double the weight loss of Ozempic, Lilly says

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results shared Wednesday.

· 7h · on MSN

Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial

· 10h · on MSN

Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

Reuters · 11h

Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial

Eli Lilly (LLY.N) said on Wednesday its experimental next-generation obesity drug, retatrutide, outperformed Novo Nordisk's Ozempic on blood sugar control and delivered more than double the weight lo...

· 10h

Missed Eli Lilly's Run? What Holders Had To Believe

· 3h

Lilly’s retatrutide beats Ozempic in head-to-head trial

· 12h

Eli Lilly (LLY) reports earnings tomorrow: what to expect

Eli Lilly beat analysts' revenue expectations last quarter, reporting revenues of $22.97 billion, up 47.7% year on year.

The News International · 8h

Lilly’s next-gen drug outperforms Ozempic in weight loss trial

· 10h

Strong Results, Guidance Boost Eli Lilly Shares Ahead of Earnings

10hon MSN

Weight-loss drug could help address nighttime sleep disruptions for millions

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as cardiovascular benefits.

GLP-1 drug coverage is being dropped by employer plans: What to know about 2027 weight-loss options

Coverage of GLP-1 drugs for weight loss is being dropped by many employer-sponsored healthcare plans as premiums soar, though workers have some new options.

1don MSN

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.

5don MSN

More people now use GLP-1s to lose weight than for other health issues

Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.

8don MSN

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

health

Weight Loss After 65: Tips for Talking With Your Doctor at Your Annual Wellness Visit

Learn how adults over 65 can discuss weight loss options with their doctor, including nutrition, exercise, medications, and surgery, for healthy aging and mobility.

Daily Dose: New heart guidelines for women, a next-gen weight loss drug beats Ozempic and what new data reveals about profound autism

Today's health headlines include four medical groups unveiling a lifelong heart health roadmap for women, from first period through menopause, built around key hormonal changes. (Adobe Stock Photo)